Hirakata, Japan

Atuyuki Takanabe


Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 153(Granted Patents)


Company Filing History:


Years Active: 1980-1981

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Atuyuki Takanabe: Innovator in Pharmaceutical Chemistry

Introduction

Atuyuki Takanabe is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents, Takanabe's work focuses on innovative solutions for health-related challenges.

Latest Patents

Takanabe's latest patents include a process for the preparation of cholesterol derivatives. These derivatives are represented by a specific general formula and are effective as immunosuppressive or anti-inflammatory agents. Another significant patent involves pyrrolo benzodiazepine compounds, which are novel perhydro-1H-pyrrolo[2,1-C][1,4]benzodiazepin-5-one compounds exhibiting antitumor activity. These compounds serve as synthetic intermediates and include processes for their production.

Career Highlights

Atuyuki Takanabe is currently associated with The Green Cross Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that address critical health issues, showcasing his commitment to innovation in the pharmaceutical industry.

Collaborations

Takanabe has collaborated with esteemed colleagues such as Yoshio Arakawa and Daisuke Satoh. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Atuyuki Takanabe's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has the potential to improve health outcomes for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…